JAMA Neurology

JAMA Neurology JAMA Neurology is a member of the JAMA Network, a consortium of peer-reviewed publications.

Official page for JAMA Neurology http://jamaneuro.com, an international, peer-reviewed journal published weekly online and monthly in print.

Long-term exposure to wildfire smoke is associated with an increased risk of dementia, particularly among racially minor...
01/26/2025

Long-term exposure to wildfire smoke is associated with an increased risk of dementia, particularly among racially minoritized patient subgroups and those living in high-poverty areas in Southern California. https://ja.ma/3PMFan0

The representation of women and racial/ethnic minorities among US neurology faculty still lags behind the overall US pop...
01/25/2025

The representation of women and racial/ethnic minorities among US neurology faculty still lags behind the overall US population, especially in senior academic ranks and leadership positions. https://ja.ma/40jEudO

Most viewed in the last 7 days from JAMA Neurology: Several factors, mostly modifiable, were associated with a higher ri...
01/25/2025

Most viewed in the last 7 days from JAMA Neurology: Several factors, mostly modifiable, were associated with a higher risk of young-onset .

https://ja.ma/40WrnRv

While children of women with epilepsy did not differ in neuropsychological abilities at age 6, the level of antiseizure ...
01/24/2025

While children of women with epilepsy did not differ in neuropsychological abilities at age 6, the level of antiseizure medication exposure during pregnancy was associated with verbal abilities. https://ja.ma/40EzGkx

A man aged 61 years presented with chronic progressive weakness and gait dysfunction over a 4-year period. Take the Clin...
01/23/2025

A man aged 61 years presented with chronic progressive weakness and gait dysfunction over a 4-year period. Take the Clinical Challenge. What is your diagnosis?

https://ja.ma/3E9i9Z5

Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerat...
01/23/2025

Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerative disease.

https://ja.ma/42iuX9h

Thrombolysis with prourokinase was not superior to standard care to improve the functional outcomes for patients with mi...
01/22/2025

Thrombolysis with prourokinase was not superior to standard care to improve the functional outcomes for patients with mild ischemic stroke within 4.5 hours of symptom onset and had a similar safety profile.

https://ja.ma/3C80i4b

Autoantibodies targeting the astrocytic intermediate filament protein vimentin were identified in patients with previous...
01/21/2025

Autoantibodies targeting the astrocytic intermediate filament protein vimentin were identified in patients with previously undifferentiated meningoencephalomyelitis. https://ja.ma/42oh75A

ARIA-E in Alzheimer disease is more likely in those with APOE ε4, microhemorrhages, low CSF Aβ42, and high Fazekas score...
01/20/2025

ARIA-E in Alzheimer disease is more likely in those with APOE ε4, microhemorrhages, low CSF Aβ42, and high Fazekas scores, but it does not generally worsen long-term cognition or function. https://ja.ma/3DQRYWS

This Viewpoint discusses using digital biomarkers for neurodegenerative disease. https://ja.ma/4gIwry9
01/19/2025

This Viewpoint discusses using digital biomarkers for neurodegenerative disease. https://ja.ma/4gIwry9

Case report describes a young patient with multiple posterior circulation embolic stroke of undermined source who was fo...
01/18/2025

Case report describes a young patient with multiple posterior circulation embolic stroke of undermined source who was found to have a V3 segment vertebral artery web. https://ja.ma/40fGh3n

Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerat...
01/18/2025

Most viewed in the last 7 days from JAMA Neurology: This Viewpoint discusses using digital biomarkers for neurodegenerative disease.

https://ja.ma/4ap8zNu

In this randomized clinical trial, iron chelation with deferiprone accelerated Alzheimer disease progression. https://ja...
01/17/2025

In this randomized clinical trial, iron chelation with deferiprone accelerated Alzheimer disease progression. https://ja.ma/3PzaRAf

Viewpoint: Although genetic therapies have shown significant promise, a centralized registry for systematic data sharing...
01/16/2025

Viewpoint: Although genetic therapies have shown significant promise, a centralized registry for systematic data sharing could enhance patient safety and improve therapeutic outcomes. https://ja.ma/4hdS7Cc

Most viewed in the last 7 days from JAMA Neurology: Anti-CGRP mAbs did not appear to elevate CVD risk compared with onab...
01/16/2025

Most viewed in the last 7 days from JAMA Neurology: Anti-CGRP mAbs did not appear to elevate CVD risk compared with onabotulinumtoxinA among Medicare beneficiaries with migraine, a population underrepresented in clinical trials.

https://ja.ma/3DRWd4A

The Get With the Guidelines-Stroke program has improved stroke care quality since 2003, increasing the population-level ...
01/15/2025

The Get With the Guidelines-Stroke program has improved stroke care quality since 2003, increasing the population-level value measured in quality-adjusted life-years. https://ja.ma/4fUVmgE

Brain hypometabolism, detected by FDG-PET, begins in the prodromal stages of dementia with Lewy bodies (DLB) and progres...
01/14/2025

Brain hypometabolism, detected by FDG-PET, begins in the prodromal stages of dementia with Lewy bodies (DLB) and progressively worsens. https://ja.ma/4hg45LH

In patients with hereditary transthyretin amyloidosis with polyneuropathy, treatment with patisiran resulted in better o...
01/13/2025

In patients with hereditary transthyretin amyloidosis with polyneuropathy, treatment with patisiran resulted in better outcomes and survival than those receiving placebo. https://ja.ma/3WcZOjX

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

(312) 670-7827

Website

Alerts

Be the first to know and let us send you an email when JAMA Neurology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to JAMA Neurology:

Videos

What Distinguishes JAMA Neurology—Editor Andrew Josephson, MD
What Distinguishes JAMA Neurology—Editor Andrew Josephson, MD

A high impact factor, fast decision time, and wide reach are a few reasons why JAMA Neurology is a valued resource for authors and readers across the field. EIC Andrew Josephson, MD, shares the journal’s evolution. For more on the journal’s accomplishments, read the Year in Review: https://ja.ma/3JHFJM5

Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease
Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease

Can a commercial blood test identify Alzheimer disease pathology? Watch this video about a recent JAMA Neurology study. https://ja.ma/43fdFsf

Shortcuts

Share

Category